SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Turkish Journal of Internal Medicine
Volume:2 Issue:1
SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control

Pages : 1-4

View : 16 | Download : 12

Publication Date : 2020-01-29

Article Type : Editorial

Abstract :Type 2 diabetes mellitus is a growing public health problem worldwide. It has a close relation with metabolic problems like obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular diseases. There are different antidiabetic agents being used in the treatment of diabetes mellitus with different mechanisms of action and a patient centered approach is required when choosing the appropriate treatment option. Sodium-glucose cotransporter insert ignore into journalissuearticles values(SGLT); 2 inhibitors also called glucoretics or gliflozins are members of a relatively new group of antidiabetic agents with promising cardioprotective and renoprotective effects beyond their glucose lowering efficacies.
Keywords : SGLT2 inhibitor, glycemic control

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.